Fatal Aeromonas hydrophila bacteremia in a hemodialysis patient treated with deferoxamine

S. H. Lin, S. D. Shieh, Y. F. Lin, E. De Brauwer, H. W. Van Landuyt, B. Gordts, J. R. Boelaert

研究成果: 雜誌貢獻文章

19 引文 斯高帕斯(Scopus)

摘要

A 49-year-old woman undergoing long-term hemodialysis and treated with deferoxamine (DFO) 1.5 g twice weekly for aluminum bone disease developed fever and bilateral calf pain caused by myonecrosis with gas gangrene. She had a rapidly fatal outcome. The cultures of blood and aspirates from both calf muscles demonstrated Aeromonas hydrophila. No obvious entry point could tie traced. The in vitro growth of the patient's strain was found to be stimulated by the deferoxamine-iron complex in an iron-deprived medium. It is suggested that high-dose DFO therapy in this patient was responsible for promoting a bacterial infection by this microorganism.

原文英語
頁(從 - 到)733-735
頁數3
期刊American Journal of Kidney Diseases
27
發行號5
出版狀態已發佈 - 1996
對外發佈Yes

ASJC Scopus subject areas

  • Nephrology

指紋 深入研究「Fatal Aeromonas hydrophila bacteremia in a hemodialysis patient treated with deferoxamine」主題。共同形成了獨特的指紋。

  • 引用此

    Lin, S. H., Shieh, S. D., Lin, Y. F., De Brauwer, E., Van Landuyt, H. W., Gordts, B., & Boelaert, J. R. (1996). Fatal Aeromonas hydrophila bacteremia in a hemodialysis patient treated with deferoxamine. American Journal of Kidney Diseases, 27(5), 733-735.